Slate Bio
VA - CharlottesvilleBiotechnology
Focus: Slate Bio is a pre-revenue biotechnology company focused on developing Treg (regulatory T cell) therapies for autoimmune diseases and oncology indications. The company operates as a clinical-stage biotech with a specialized immunology focus from its Charlottesville, VA headquarters.
Profile data last refreshed 13h ago · AI intelligence enriched 1w ago
Open Jobs
1+1 this month
Stable — net +1 jobs in 30d
2 added, 1 removed. Backfill posture.
Should You Work at Slate Bio?
AI assessmentSlate Bio represents a high-risk, high-reward early-stage opportunity suitable only for scientists willing to accept pre-clinical stage uncertainty and equity-driven compensation.
Why Work Here
- Opportunity to work on cutting-edge Treg cell therapy platform, a differentiated approach with limited direct competition in autoimmune space
- Early-stage biotech environment offers potential for significant equity upside and hands-on contribution to pipeline advancement
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Interview Prep Quick Facts
Help build intelligence for Slate Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.